AI assistant
XERO LIMITED — Director's Dealing 2017
Jul 31, 2017
66106_rns_2017-07-31_4a61c2d7-b559-48cb-b2c7-072615680455.pdf
Director's Dealing
Open in viewerOpens in your device viewer

Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
| To NZX Limited; and | |
|---|---|
| Name of listed issuer: | |
| Date this disclosure made: | |
| Date of last disclosure: |
Director or senior manager giving disclosure
Full name(s): Name of listed issuer:
Name of related body corporate (if applicable):
Position held in listed issuer:
| Xero Limited (XRO) | |
|---|---|
| August 2017 | |
| 8 June 2017 |
| Duncan Ritchie |
|---|
| Xero Limited (XRO) |
| Not applicable |
| Ceased role as Chief Product and Platform Officer on 28 May 2017 |
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
| Class of affected quoted financial products: | Ordinary shares in Xero Limited (Ordinary Shares) |
|---|---|
| Nature of the affected relevant interest(s): | Beneficial ownership of Ordinary Shares through the Xero Limited Employee Restricted Share Plan (Plan) |
| For that relevant interest- | |
| Number held in class before acquisition or disposal: | 6.035 |
| Number held in class after acquisition or disposal: | 10.647 |
| Current registered holder(s): | Xero Trustee Limited |
| Registered holder(s) once transfers are registered: | Xero Trustee Limited |
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
| Type of affected derivative: |
|---|
| Class of underlying financial products: |
| Details of affected derivative- |
| The notional value of the derivative (if any) or the notional amount of underlying financial products $($ if any $)$ : |
| A statement as to whether the derivative is cash settled or physically settled: |
Maturity date of the derivative (if any):
Expiry date of the derivative(if any):
The price specified in the terms of the derivative (if any):
Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products:
For that derivative,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative:
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates:
Details of transactions requiring disclosure-
Date of transaction:
| Kero Trustee Limited | |
|---|---|
| Kero Trustee Limited | |
Not applicable Not applicable
| Not applicable | |
|---|---|
| Not applicable | |
| Not applicable | |
| Not applicable | |
| Not applicable | |
Not applicable
Not applicable
Not applicable
| 28 July 2017 | |
|---|---|
Nature of transaction:
Name of any other party or parties to the transaction (if known):
The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value, describe the consideration:
Number of financial products to which the transaction related:
If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details
Whether relevant interests were acquired or disposed of during a closed period:
Whether prior written clearance was provided to allow the acquisition or disposal to proceed during the closed period:
Date of the prior written clearance (if any):
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:
Nature of relevant interest:
For that relevant interest,-
Number held in class:
Current registered holder(s):
For a derivative relevant interest,-
Type of derivative:
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying financial products (if any):
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative (if any):
The price's specified terms (if any):
Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products:
For that derivative relevant interest,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative:
Certification
I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made
| Allocation of 4,612 Ordinary Shares under the Plan |
|
|---|---|
| Not applicable | |
| Ordinary Shares allocated, as part of the remuneration package of Duncan Ritchie at a value of NZ\$25.75 per share (being the 20 day volume weighted average market price of Ordinary Shares on the NZX Main Board through to 27 July 2017) |
|
| No |
|---|
| Not applicable |
| Not applicable |
| (a) Ordinary Shares; (b) Options to acquire Ordinary Shares (Options) |
|---|
| (a) Legal ownership of Ordinary Shares; (b) Holder of Options, each Option entitling the holder to subscribe for one Ordinary Share subject to the terms of the Xero Limited Restricted Stock Unit and Option Plan (NZ) |
| (a) 63,176; (b) 135,000 |
|---|
| (a) Duncan Ritchie; (b) Duncan Ritchie |
Not applicable
| Not applicable |
|---|
| Not applicable |
| Not applicable |
| Not applicable |
| Not applicable |
| Not applicable |
| Not applicable |
| Not applicable |
| Not applicable |
DocuSign Envelope ID: 9B49D5B9-4B96-4D77-ABEC-D11A97B3C7E1
Signature of director or officer:
Date of signature:
Docusigned by:
Duncan Ritchie -CFF3865064DA413... 30 July 2017 | 23:36:12 PDT
